Nanobac Pharmaceuticals Incorporated (NNBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1996 | 12-1995 | 12-1994 | 12-1993 | 12-1992 | |
| Sales | 8,870 | 6,230 | 3,700 | 2,760 | 2,006 |
| Cost of Goods | N/A | N/A | N/A | N/A | 1,019 |
| Gross Profit | 8,870 | 6,230 | 3,700 | 2,760 | 986 |
| Operating Expenses | 10,840 | 7,900 | 3,800 | 3,070 | 985 |
| Operating Income | -1,970 | -1,670 | -100 | -310 | 20 |
| Interest Expense | 560 | 330 | 270 | 300 | 301 |
| Other Income | 1,290 | 990 | 570 | 510 | 43 |
| Pre-tax Income | -1,240 | -1,010 | 200 | -100 | -239 |
| Income Tax | N/A | -180 | 9 | N/A | 0 |
| Net Income Continuous | -1,240 | -830 | 191 | -100 | -239 |
| Net Income | $-1,240 | $-830 | $190 | $-100 | $-239 |
| EPS Basic Total Ops | -0.58 | -0.49 | 0.11 | N/A | N/A |
| EPS Basic Continuous Ops | -0.58 | -0.49 | 0.11 | N/A | N/A |
| EBITDA(a) | $-760 | $-790 | $460 | $190 | $478 |